| Title : Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects - Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| Author(s) : Graefe-Mody U , Rose P , Ring A , Zander K , Iovino M , Woerle HJ |
| Ref : Drug Metab Pharmacokinet , 26 :123 , 2011 |
| Abstract : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| ESTHER : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| PubMedSearch : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| PubMedID: 21084763 |
| Title : Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects - Retlich_2010_Clin.Pharmacokinet_49_829 |
| Author(s) : Retlich S , Duval V , Ring A , Staab A , Huttner S , Jungnik A , Jaehde U , Dugi KA , Graefe-Mody U |
| Ref : Clinical Pharmacokinetics , 49 :829 , 2010 |
| Abstract : Retlich_2010_Clin.Pharmacokinet_49_829 |
| ESTHER : Retlich_2010_Clin.Pharmacokinet_49_829 |
| PubMedSearch : Retlich_2010_Clin.Pharmacokinet_49_829 |
| PubMedID: 21053992 |
| Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409 |
| Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA |
| Ref : Diabet Med , 27 :1409 , 2010 |
| Abstract : Forst_2010_Diabet.Med_27_1409 |
| ESTHER : Forst_2010_Diabet.Med_27_1409 |
| PubMedSearch : Forst_2010_Diabet.Med_27_1409 |
| PubMedID: 21059094 |